Evidence map›Paper›PMID 26347895›Full record

ArticleJournal of immunology research2015

SP140L, an Evolutionarily Recent Member of the SP100 Family, Is an Autoantigen in Primary Biliary Cirrhosis.

Mario Saare, Uku Hämarik, Rainis Venta, Marina Panarina, Chiara Zucchelli, Maire Pihlap, Anu Remm, Kai Kisand, Urve Toots, Kaidi Möll and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Sp140L functions as a herpesvirus restriction factor suppressing viral transcription and activating interferon-stimulated genes.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. A Closer Look into Autoimmune Liver Diseases.International journal of molecular sciences · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Autoantibodies to speckled protein family in primary biliary cholangitis.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2021
    Article
  17. Review
  18. Article
  19. The Fate of Speckled Protein 100 (Sp100) During Herpesviruses Infection.Frontiers in cellular and infection microbiology · 2020
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Mario SaareMolecular Pathology Group, Institute of Biomedicine and Translational Medicine, University of Tartu, 50411 Tartu, Estonia.
Uku HämarikMolecular Pathology Group, Institute of Biomedicine and Translational Medicine, University of Tartu, 50411 Tartu, Estonia.
Rainis VentaInstitute of Technology, University of Tartu, 50411 Tartu, Estonia.
Marina PanarinaDepartment of Immunology, Institute of Biomedicine and Translational Medicine, University of Tartu, 50411 Tartu, Estonia.
Chiara ZucchelliBiomolecular NMR Laboratory, Dulbecco Telethon Institute c/o S. Raffaele Scientific Institute, 20132 Milan, Italy.
Maire PihlapMolecular Pathology Group, Institute of Biomedicine and Translational Medicine, University of Tartu, 50411 Tartu, Estonia.
Anu RemmMolecular Pathology Group, Institute of Biomedicine and Translational Medicine, University of Tartu, 50411 Tartu, Estonia.
Kai KisandMolecular Pathology Group, Institute of Biomedicine and Translational Medicine, University of Tartu, 50411 Tartu, Estonia.
Urve TootsIcosagen AS, 61713 Tartumaa, Estonia.
Kaidi MöllIcosagen AS, 61713 Tartumaa, Estonia.
Riina SalupereDepartment of Internal Medicine, Tartu University Hospital, 51014 Tartu, Estonia.
Giovanna MuscoBiomolecular NMR Laboratory, Dulbecco Telethon Institute c/o S. Raffaele Scientific Institute, 20132 Milan, Italy.
Raivo UiboDepartment of Immunology, Institute of Biomedicine and Translational Medicine, University of Tartu, 50411 Tartu, Estonia.
Pärt PetersonMolecular Pathology Group, Institute of Biomedicine and Translational Medicine, University of Tartu, 50411 Tartu, Estonia.
University of Tartu · EEDulbecco Telethon Institute · ITIcosagen (Estonia) · EETartu University Hospital · EE

Funding

Telethon TCR07003
6 · The paper itself

Abstract

The SP100 family members comprise a set of closely related genes on chromosome 2q37.1. The widely expressed SP100 and the leukocyte-specific proteins SP110 and SP140 have been associated with transcriptional regulation and various human diseases. Here, we have characterized the SP100 family member SP140L. The genome sequence analysis showed the formation of SP140L gene through rearrangements of the two neighboring genes, SP100 and SP140, during the evolution of higher primates. The SP140L expression is interferon-inducible with high transcript levels in B cells and other peripheral blood mononuclear cells. Subcellularly, SP140L colocalizes with SP100 and SP140 in nuclear structures that are devoid of SP110, PML, or p300 proteins. Similarly to SP100 and SP140 protein, we detected serum autoantibodies to SP140L in patients with primary biliary cirrhosis using luciferase immunoprecipitation system and immunoblotting assays. In conclusion, our results show that SP140L is phylogenetically recent member of SP100 proteins and acts as an autoantigen in primary biliary cirrhosis patients.

Indexed as

Evolution, MolecularAdultAgedAged, 80 and overAnimalsAntigens, NuclearAutoantibodiesAutoantigensCase-Control StudiesCell LineCell NucleusCloning, MolecularDNA, ComplementaryGene DuplicationGene ExpressionGene Expression RegulationAntigens, NuclearAutoantibodiesAutoantigensDNA, ComplementaryInterferonsSP140 protein, humanTranscription Factors

Identifiers

PMID26347895
PMCPMC4548144
OpenAlexW1499184208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.